var gene regulation and antigenic variation in malaria

描述(申请人提供)：恶性疟原虫是人类最严重的疟疾的病原体，这种疾病每年导致100多万人死亡，其中大部分是非洲的幼儿。这些原生动物寄生虫入侵并最终破坏其宿主的循环红细胞(RBC)，导致严重贫血以及经常致命的脑型疟疾和妊娠疟疾综合征。在感染过程中，出现具有改变抗原表型的小亚群寄生虫，从而避免宿主的抗体反应。这一过程被称为抗原变异，是该病的持续性以及在恶性疟原虫感染中经常观察到的寄生虫血症波动的原因。恶性疟原虫感染红细胞的抗原性变异是由于多拷贝var基因家族成员之间表达的转换所致。每个var基因编码一种不同形式的蛋白质，称为PfEMP1。这种蛋白被放置在受感染的红细胞表面，并介导与感染者血管壁内皮细胞表面上发现的特定受体的黏附。这种粘附性是感染恶性疟原虫的许多疾病表现的原因，包括脑型疟疾和妊娠疟疾。任何给定的寄生虫一次只表达一个var基因，因此决定了感染细胞的抗原表型和它们的粘附性。因此，var基因的表达是疟疾感染的抗原变异和毒力的核心。本项目旨在了解疟疾寄生虫调控var基因表达和抗原变异的分子机制。先前的工作已经证明，var基因的互斥表达涉及对每个var基因染色质结构的特定修改，然而这些修改是如何协调以导致一个60人家族中只有一个基因一次表达的尚不清楚。该项目的具体目标是：1)鉴定和鉴定调节var基因染色质组装的染色质边界/绝缘子元件；2)确定非编码RNA在针对var基因位点的染色质组装中的作用；3)研究与妊娠相关疟疾有关的特定var基因的翻译调控机制。实验设计依赖于使用报告基因和药物可选标记创建转基因寄生虫系，以快速确定这些调控元件在控制var基因表达中的作用。长期目标是开发方法来扰乱抗原变异的过程，从而缩短感染的长度并降低其严重性。公共卫生意义：疟疾仍然是当今世界最重要的传染病杀手之一，每年造成100多万人死亡，主要是撒哈拉以南非洲的幼儿。该项目的重点是疟疾寄生虫避开人类免疫反应并引发严重疾病的能力。更好地了解这些过程将导致新的、新的治疗形式，这将有助于减轻疟疾给发展中国家造成的巨大公共卫生负担。

DESCRIPTION (provided by applicant): Plasmodium falciparum is the causative agent responsible for the most severe form of human malaria, a disease that kills more than a million people a year, mostly young children in Africa. These protozoan parasites invade and ultimately destroy circulating red blood cells (RBCs) of their host, leading to severe anemia and the frequently lethal syndromes of cerebral malaria and pregnancy associated malaria. Over the course of an infection, small sub-populations of parasites arise that have an altered antigenic phenotype, thus avoiding the antibody response of the host. This process is referred to as antigenic variation and is responsible for the persistent nature of the disease as well as the waves of parasitemia frequently observed in P. falciparum infections. Antigenic variation of P. falciparum infected RBCs results from switches in expression between individual members of the multi-copy var gene family. Each var gene encodes a different form of a protein called PfEMP1. This protein is placed on the surface of the infected RBCs and mediates adhesion to specific receptors found on the endothelial surfaces of the blood vessel walls of the infected individual. This adhesion is responsible for many of the disease manifestations of infection with P. falciparum, including both cerebral malaria and pregnancy associated malaria. Only a single var gene is expressed at a time by any given parasite, thus determining both the antigenic phenotype of the infected cells as well as their adhesive properties. Therefore var gene expression is the heart of both antigenic variation and virulence of malaria infections. This project is designed to understand the molecular mechanisms the regulate var gene expression and antigenic variation by malaria parasites. Previous work has demonstrated that mutually exclusive expression of var genes involves specific modifications to the chromatin structure at each var gene, however how these modifications are coordinated to result in expression of only a single gene at a time out of a family of 60 remains unknown. The specific aims of the project are 1) to identify and characterize chromatin boundary/insulator elements that regulate chromatin assembly at var genes, 2) to determine the role of noncoding RNAs in targeting chromatin assembly to var gene loci, and 3) to investigate the mechanism of translational regulation of a specific var gene implicated in pregnancy associated malaria. The experimental design relies on creating transgenic parasite lines using reporter genes and drug selectable markers to rapidly determine the role of these regulatory elements in controlling var gene expression. The long-term goals are to develop methods to disrupt the process of antigenic variation and thereby shorten the length of an infection and reduce its severity. PUBLIC HEALTH RELEVANCE: Malaria remains one of the most important infectious disease killers in the world today, causing more than a million deaths annually, primarily of young children in sub-Saharan Africa. This project focuses on the ability of malaria parasites to avoid the human immune response and to cause severe disease. A better understanding of these processes will lead to new, novel forms of treatment that will help to relieve the enormous public health burden that malaria inflicts on the developing world.